Anastasia Hoover

Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis

Fady T. Botros, Hertzel C. Gerstein, Raleigh Malik et al. · Diabetes Care · 2023 · 37 citations

Medicine, Nephrology, Pharmacotherapy +17

OP26 Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active Ulcerative Colitis: Results from the Phase 3 LUCENT-1 study

Geert D’Haens, Taku Kobayashi, Nathan Morris et al. · Journal of Crohn s and Colitis · 2022 · 27 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the <scp>REWIND</scp> randomized trial

Peter Raubenheimer, William C. Cushman, Álvaro Avezum et al. · Diabetes Obesity and Metabolism · 2022 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +17

Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis

Hertzel C. Gerstein, Shun-Fu Lee, Guillaume Paré et al. · Diabetes Care · 2023 · 11 citations

Pharmacy, Endocrinology, Pharmacology +15